OncoMatch/Clinical Trials/NCT05277688
Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients
Is NCT05277688 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies adjuvant concurrent chemoradiotherapy for cervical cancer.
Treatment: adjuvant concurrent chemoradiotherapy — To evaluate if adjuvant concurrent chemoradiotherapy is associated with a recurrence-free survival benefit in comparison with radiotherapy alone in selected intermediate risk cervical cancer after radical surgery.
Check if I qualifyExtracted eligibility criteria
Cancer type
Cervical Cancer
Disease stage
Required: Stage IA2, IB, IIA, IIB
Prior therapy
Must have received: radical hysterectomy — adjuvant
Accepted radical hysterectomy 3-4 weeks before
Cannot have received: chemotherapy
no previous chemotherapy
Cannot have received: radiotherapy
no previous...radiotherapy
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify